(Q42779702)

7 November 2017

The legend of cytomegalovirus and glioblastoma lives on. (English)

1 reference

7 November 2017

1 reference

1

Michael Weller

1 reference

7 November 2017

Riccardo Soffietti

2

1 reference

7 November 2017

Michael Brada

series ordinal

3

1 reference

7 November 2017

language of work or name

1 reference

4 December 2013

1 reference

7 November 2017

1 reference

7 November 2017

16

1 reference

7 November 2017

1

1 reference

7 November 2017

166

1 reference

Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study

7 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3870830

PubMed Central

reference URL

Survival in patients with glioblastoma receiving valganciclovir

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3870830

PubMed Central

reference URL

16 August 2018

Identifiers

DOI

10.1093/NEUONC/NOT204

1 reference

7 November 2017

1 reference

7 November 2017

PubMed publication ID

24311642

1 reference